Literature DB >> 8986674

New developments in topical estrogen therapy.

R Jewelewicz1.   

Abstract

OBJECTIVE: To review new developments in transdermal E2 therapy in postmenopausal women.
DESIGN: A bibliographic search (Medline) of the medical literature from 1966 through 1995 was used to identify new studies evaluating transdermal E2. PATIENT(S): Menopausal and postmenopausal women. RESULT(S): Like oral estrogen, transdermal E2 relieves menopausal symptoms, reverses urogenital atrophy, and conserves bone economy. Initial studies have demonstrated beneficial effects of transdermal E2 on cardiovascular function. Quality of life, patient satisfaction, and compliance also improve with transdermal E2. Advances in transdermal delivery continue to emerge, including low-dose systems and patches that maintain serum E2 levels for a full 7-day period. CONCLUSION(S): New developments in transdermal administration have the potential to increase the number of postmenopausal women who accept and are compliant with long-term estrogen replacement therapy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8986674     DOI: 10.1016/s0015-0282(97)81846-8

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  2 in total

1.  Do we need clinical trials to test the ability of transdermal HRT to prevent coronary heart disease?

Authors:  David Crook
Journal:  Curr Control Trials Cardiovasc Med       Date:  2001

2.  The effects of transdermal and oral oestrogen replacement therapy on colorectal cancer risk in postmenopausal women.

Authors:  I Csizmadi; J-P Collet; A Benedetti; J-F Boivin; J A Hanley
Journal:  Br J Cancer       Date:  2004-01-12       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.